Published in Int J Methods Psychiatr Res on March 01, 2010
Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the US example. Popul Health Metr (2010) 1.86
Burden of disease associated with alcohol use disorders in the United States. Alcohol Clin Exp Res (2014) 1.09
Disability associated with alcohol abuse and dependence. Alcohol Clin Exp Res (2010) 1.08
Disability Weights Measurement for 228 Causes of Disease in the Korean Burden of Disease Study 2012. J Korean Med Sci (2016) 1.05
Global burden of injuries attributable to alcohol consumption in 2004: a novel way of calculating the burden of injuries attributable to alcohol consumption. Popul Health Metr (2012) 0.93
Using disability-adjusted life years to set health-based targets: a novel use of an established burden of disease metric. J Public Health Policy (2013) 0.80
A narrative review of alcohol consumption as a risk factor for global burden of disease. Subst Abuse Treat Prev Policy (2016) 0.78
Using surveys to calculate disability-adjusted life-year. Alcohol Res (2013) 0.77
Disability Weights for Chronic Mercury Intoxication Resulting from Gold Mining Activities: Results from an Online Pairwise Comparisons Survey. Int J Environ Res Public Health (2017) 0.75
Establishing disability weights for congenital pediatric surgical conditions: a multi-modal approach. Popul Health Metr (2017) 0.75
Disability weights based on patient-reported data from a multinational injury cohort. Bull World Health Organ (2016) 0.75
Estimation of Disability Weights in the General Population of South Korea Using a Paired Comparison. PLoS One (2016) 0.75
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
EuroQol--a new facility for the measurement of health-related quality of life. Health Policy (1990) 59.70
EuroQol: the current state of play. Health Policy (1996) 27.78
EQ-5D: a measure of health status from the EuroQol Group. Ann Med (2001) 18.69
Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ (1994) 10.96
An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data. Psychol Methods (2004) 9.11
The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ (1994) 6.99
Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care (2002) 6.63
A critical examination of summary measures of population health. Bull World Health Organ (2000) 5.15
Multiple-informant ranking of the disabling effects of different health conditions in 14 countries. WHO/NIH Joint Project CAR Study Group. Lancet (1999) 5.02
Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess (2001) 4.31
The utility of different health states as perceived by the general public. J Chronic Dis (1978) 3.65
The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med (2001) 3.57
Progress and directions in refining the global burden of disease approach: a response to Williams. Health Econ (2000) 3.17
Validation of the Subjective Numeracy Scale: effects of low numeracy on comprehension of risk communications and utility elicitations. Med Decis Making (2007) 2.89
The rule of rescue. Soc Sci Med (2003) 2.63
Should substance use disorders be considered as categorical or dimensional? Addiction (2006) 2.48
The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ (1999) 2.46
Whose utilities for decision analysis? Med Decis Making (1990) 2.12
Is there a case for using visual analogue scale valuations in cost-utility analysis? Health Econ (2006) 2.08
Theory versus practice: a review of 'willingness-to-pay' in health and health care. Health Econ (2001) 1.89
Assessing values for health: numeracy matters. Med Decis Making (2001) 1.78
Inconsistency over time in the preferences of older persons with advanced illness for life-sustaining treatment. J Am Geriatr Soc (2007) 1.73
Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data. Popul Health Metr (2003) 1.63
The relevance of health state after treatment in prioritising between different patients. J Med Ethics (1993) 1.53
Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics (2000) 1.51
Health measurement in the third era of health. Am J Public Health (2005) 1.50
The effect of search procedures on utility elicitations. Med Decis Making (1998) 1.47
Involving the general public in priority setting: experiences from Australia. Soc Sci Med (2003) 1.46
Several methods to investigate relative attribute impact in stated preference experiments. Soc Sci Med (2007) 1.46
Are QALYs based on time trade-off comparable?--A systematic review of TTO methodologies. Health Econ (2005) 1.41
Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life. Qual Life Res (1993) 1.37
Are disability weights universal? WHO/NIH Joint Project CAR Study Group. Lancet (1999) 1.36
Comparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-weights. Med Decis Making (2008) 1.31
An inquiry into the different perspectives that can be used when eliciting preferences in health. Health Econ (2003) 1.31
The trade-off between severity of illness and treatment effect in cost-value analysis of health care. Health Policy (1993) 1.31
A comparison of individual and social time trade-off values for health states in the general population. Health Policy (2005) 1.26
Utilities measured by rating scale, time trade-off, and standard gamble: review and reference for health care professionals. J Epidemiol (2002) 1.25
Measuring population health: a review of indicators. Annu Rev Public Health (2006) 1.22
Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. J Health Econ (2005) 1.16
The importance of perspective in the measurement of quality-adjusted life years. Med Decis Making (1997) 1.15
The standard gamble method: what is being measured and how it is interpreted. Health Serv Res (1994) 1.14
Concerns for the worse off: fair innings versus severity. Soc Sci Med (2005) 1.11
On the assessment of preferences for health and duration: maximal endurable time and better than dead preferences. Med Care (2007) 1.09
The influence of subjective expectations about length and quality of life on time trade-off answers. Health Econ (2004) 1.03
The impact of considering adaptation in health state valuation. Soc Sci Med (2005) 1.03
The construction of standard gamble utilities. Health Econ (2008) 1.02
Is the person trade-off a valid method for allocating health care resources? Health Econ (1997) 1.01
Eliciting Canadian population preferences for health states using the Classification and Measurement System of Functional Health (CLAMES). Chronic Dis Can (2007) 1.01
Being there is important, but getting there matters too: the role of path in the valuation process. Med Decis Making (2006) 0.98
Anchoring, Activation, and the Construction of Values. Organ Behav Hum Decis Process (1999) 0.97
A nonparametric elicitation of the equity-efficiency trade-off in cost-utility analysis. J Health Econ (2004) 0.96
Invariance and inconsistency in utility ratings. Med Decis Making (2005) 0.95
Trading people versus trading time: what is the difference? Popul Health Metr (2005) 0.95
Equity in health care prioritisation: an empirical inquiry into social value. Health Policy (2005) 0.94
On the classification of population health measurements. Am J Public Health (2004) 0.94
On the societal value of health care: what do we know about the person trade-off technique? Health Econ (2001) 0.93
Health state utilities: a framework for studying the gap between the imagined and the real. Value Health (2008) 0.93
An experimental test of question framing in health state utility assessment. Health Policy (1998) 0.93
A test of the QALY model when health varies over time. Soc Sci Med (2003) 0.93
Societal value, the person trade-off, and the dilemma of whose values to measure for cost-effectiveness analysis. Health Econ (2000) 0.92
Public preferences for prevention versus cure: what if an ounce of prevention is worth only an ounce of cure? Med Decis Making (1998) 0.91
Health state after treatment: a reason for discrimination? Health Econ (1999) 0.90
Health utility bias: a systematic review and meta-analytic evaluation. Med Decis Making (2008) 0.87
Severity of illness and priority setting: worrisome lack of discussion of surprising finding. J Health Econ (2005) 0.85
What difference does it make? The calculation of QALY gains from health profiles using patient and general population values. Health Policy (2007) 0.84
Can prospect theory explain risk-seeking behavior by terminally ill patients? Med Decis Making (2005) 0.83
Exploring the role of order effects in person trade-off elicitations. Health Policy (2002) 0.83
Equity in health: the importance of different health streams. J Health Econ (2001) 0.82
A theoretical framework for TTO valuations of health. Health Econ (2006) 0.81
Lack of multiplicative transitivity in person trade-off responses. Health Econ (2004) 0.81
The equivalence of numbers: the social value of avoiding health decline: an experimental Web-based study. BMC Med Inform Decis Mak (2002) 0.81
Understanding VAS valuations: qualitative data on the cognitive process. Qual Life Res (2005) 0.80
Relationship between age and patients' current health state preferences. Gerontologist (1999) 0.79
Why people refuse to make tradeoffs in person tradeoff elicitations: a matter of perspective? Med Decis Making (2007) 0.78
Anchoring errors in clinical-like judgments. J Clin Psychol (1990) 0.78
Comparing three versions of the time tradeoff: time for a change? Med Decis Making (1997) 0.78
Magnitude estimation and categorical rating scaling in social sciences: a theoretical and psychometric controversy. J Appl Meas (2008) 0.77
How summary measures of population health are affecting health agendas. Bull World Health Organ (2003) 0.76
Are preferences for equality a matter of perspective? Med Decis Making (2005) 0.76
The global distribution of average volume of alcohol consumption and patterns of drinking. Eur Addict Res (2003) 3.72
Global burden of disease from alcohol, illicit drugs and tobacco. Drug Alcohol Rev (2006) 2.33
Heavy metal exposure in patients suffering from electromagnetic hypersensitivity. Sci Total Environ (2009) 1.43
Burden of disease associated with alcohol use disorders in the United States. Alcohol Clin Exp Res (2014) 1.09
Mortality in heroin-assisted treatment in Switzerland 1994-2000. Drug Alcohol Depend (2005) 1.08
Prevalence of and potential influencing factors for alcohol dependence in Europe. Eur Addict Res (2014) 1.03
Neuronal correlates of symptom formation in functional somatic syndromes: a fMRI study. Neuroimage (2008) 0.95
The relationship between legal status, perceived pressure and motivation in treatment for drug dependence: results from a European study of Quasi-Compulsory Treatment. Eur Addict Res (2006) 0.92
Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS). Neuro Endocrinol Lett (2007) 0.88
Early post-convulsive prolongation of QT time in children. Acta Paediatr (2005) 0.88
Association of tinnitus and electromagnetic hypersensitivity: hints for a shared pathophysiology? PLoS One (2009) 0.87
High-frequency priming stimulation does not enhance the effect of low-frequency rTMS in the treatment of tinnitus. Exp Brain Res (2007) 0.86
Establishing disability weights from pairwise comparisons for a US burden of disease study. Int J Methods Psychiatr Res (2013) 0.86
Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI). Psychopharmacology (Berl) (2003) 0.82
Altered cortical excitability in subjectively electrosensitive patients: results of a pilot study. J Psychosom Res (2007) 0.78
Detection and treatment of HIV and hepatitis virus infections in Swiss correctional facilities. Int J Public Health (2008) 0.78
Modulation of human motor cortex excitability by quetiapine. Psychopharmacology (Berl) (2007) 0.77
Using surveys to calculate disability-adjusted life-year. Alcohol Res (2013) 0.77
Stable motor cortex excitability in red and green lighting conditions. Neurosci Lett (2009) 0.76
[Privacy within psychiatric wards]. Psychiatr Prax (2002) 0.75